Affluent Medical SA (EPA:AFME)

Market Cap	53.89M
Revenue (ttm)	1.30M
Net Income (ttm)	-17.04M
Shares Out	39.34M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	569
Average Volume	3,270
Open	1.395
Previous Close	1.370
Day's Range	1.340 - 1.395
52-Week Range	1.190 - 2.110
Beta	0.64
RSI	52.99
Earnings Date	Mar 28, 2025

About Affluent Medical

Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 63
• Stock Exchange: Euronext Paris
• Ticker Symbol: AFME

Financial Performance

In 2023, Affluent Medical's revenue was 1.22 million, a decrease of -8.59% compared to the previous year's 1.34 million. Losses were -15.65 million, 2.80% more than in 2022.